Accipiter Biosciences logo

Accipiter Biosciences

accipiterbio.com

Accipiter Biosciences uses computational protein design to develop de novo protein therapies that engage multiple cell-surface receptors and pathways in one stable molecule. Its therapies are designed for complex diseases, including autoimmune disorders and cancer, as an alternative to combination treatments.

Facts

HQ
Seattle, Washington, US
Sectors
Biotechnology Research
Type
Corporation Seattle business license
Employees
26
Registered name
Accipiter Biosciences Inc Seattle business license
Stage
Seed
Members see funding amounts.
.

Is this your organization? Claim it

Founders

  • Matthew Bick
    Matthew Bick co-founder and Chief Executive Officer
  • Hector Rincon-Arano Co-founder and Chief Scientific Officer
  • Javier Castellanos Co-founder and Chief Technology Officer

Executives

Online